Alastair Van Heerden to Mass Screening
This is a "connection" page, showing publications Alastair Van Heerden has written about Mass Screening.
Connection Strength
0,903
-
Simultaneous alleviation of verification and reference standard biases in a community-based tuberculosis screening study using Bayesian latent class analysis. PLoS One. 2024; 19(6):e0305126.
Score: 0,203
-
The Feasibility and Acceptability of an mHealth Conversational Agent Designed to Support HIV Self-testing in South Africa: Cross-sectional Study. J Med Internet Res. 2022 12 12; 24(12):e39816.
Score: 0,183
-
Protocol: evaluation of an optimised couples-focused intervention to increase testing for HIV in rural KwaZulu-Natal, South Africa, the Igugu Lethu ('Our treasure') cohort study. BMC Public Health. 2022 08 19; 22(1):1577.
Score: 0,179
-
Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr. 2018 08 15; 78(5):522-526.
Score: 0,136
-
Changes in Stigma and Social Support among Participants in a Randomized Trial of a Novel Expanded Social Network-based HIV Testing Intervention in KwaZulu-Natal, South Africa. AIDS Behav. 2024 Aug; 28(8):2619-2629.
Score: 0,051
-
Two-way associations between relationship quality and uptake of couples health screening including HIV testing and counselling together: quantitative analysis of a couples cohort in rural South Africa. AIDS Care. 2024 Jul; 36(sup1):187-200.
Score: 0,050
-
Optimising a couples-focused intervention to increase couples' HIV testing and counselling using the person-based approach: a qualitative study in Kwa-Zulu Natal, South Africa. BMJ Open. 2021 12 01; 11(12):e047408.
Score: 0,043
-
Use of the ages and stages questionnaire adapted for South Africa and Zambia. Child Care Health Dev. 2017 01; 43(1):59-66.
Score: 0,030
-
Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Lancet HIV. 2016 05; 3(5):e212-20.
Score: 0,029